Seattle Genetics (SGEN) Misses Q1 EPS by 6c
Tweet
Share
E-mailGet Alerts SGEN Hot Sheet
Price: $228.74 --0%
Revenue Growth %: -100.0%
Financial Fact:
Investment income, net: 660K
Today's EPS Names:
MAXN, CSTR, ACU, More
Revenue Growth %: -100.0%
Financial Fact:
Investment income, net: 660K
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Seattle Genetics (NASDAQ: SGEN) reported Q1 EPS of ($0.15), $0.06 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $111.2 million versus the consensus estimate of $116.49 million.
For earnings history and earnings-related data on Seattle Genetics (SGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Benchmark on Take-Two's (TTWO) GTV 6 Release: 'we anticipate that the game will not be released within the fiscal year and expect it to launch in fiscal 2026 instead'
- Schlumberger Ltd. (SLB) Reports In-Line Q1 EPS
- Regions Financial (RF) Misses Q1 EPS by 8c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
